Immediate Impact
1 by Nobel laureates 16 from Science/Nature 61 standout
Citing Papers
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
2022 Standout
Lymph protects metastasizing melanoma cells from ferroptosis
2020 StandoutNature
Works of K. T. Flaherty being referenced
Phase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours
2019
Final results of E2603: A double-blind, randomized phase III trial comparing carboplatin (C)/paclitaxel (P) with or without sorafenib (S) in metastatic melanoma.
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. T. Flaherty | 460 | 355 | 254 | 32 | 641 | |
| Sharon Glaysher | 321 | 284 | 143 | 30 | 677 | |
| Christopher Moy | 358 | 269 | 176 | 17 | 608 | |
| Katherine R. Singleton | 492 | 206 | 189 | 16 | 643 | |
| Michaela A. Ihle | 306 | 256 | 278 | 23 | 652 | |
| Jayasree S. Nair | 412 | 302 | 103 | 21 | 704 | |
| Assunta Sgambato | 286 | 436 | 406 | 31 | 727 | |
| Sotaro Enatsu | 304 | 399 | 393 | 41 | 712 | |
| Youwei Bi | 212 | 261 | 293 | 24 | 719 | |
| Muaiad Kittaneh | 290 | 440 | 306 | 40 | 722 | |
| Kerstin Trunzer | 235 | 419 | 266 | 16 | 549 |
All Works
Loading papers...